Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives. Its vision is to use its proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic benefit.

Biotechnology

Therapeutics

Vicinitas Therapeutics

Christian Hofmann

Daniel Nomura

The Scientific Research Team at Vicinitas Therapeutics is responsible for pioneering drug discovery and development using the company's DUBTAC platform. This team of scientists and research associates conducts cutting-edge experiments to restore the levels of degraded proteins implicated in diseases, aiming to translate their findings into viable therapeutic solutions. Their work is integral to advancing the company's mission of positively impacting patient lives through innovative medical treatments.

Scientific Research Team

About

Team members

Other teams at Vicinitas Therapeutics

Leadership Team